Bacteroides thetaiotaomicron DSM 2255 is an anaerobe, mesophilic bacterium that was isolated from perforated appendix.

  1. anaerobe
  2. mesophilic
  3. 16S sequence
  4. Bacteria
  5. genome sequence
  • Availability in culture collections External linksarrow_down
  • [Ref.: #1004] Culture collection no. DSM 2255, ATCC 29741, WAL 2926, CIP 104207, CCUG 34778, NCTC 13706
    [Ref.: #71245] *
    Literature: Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries.
    Topicarrow to sort Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort
    Pathogenicity Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial. Ross JE, Scangarella-Oman N, Jones RN Diagn Microbiol Infect Dis 10.1016/j.diagmicrobio.2013.01.007 2013 *
    Metabolism Characterization of chondroitin sulfate lyase ABC from Bacteroides thetaiotaomicron WAL2926. Shaya D, Hahn BS, Park NY, Sim JS, Kim YS, Cygler M Biochemistry 10.1021/bi800353g 2008 *
    Pathogenicity Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates. Schaumann R, Petzold S, Fille M, Rodloff AC Infection 10.1007/s15010-005-5061-9 2005 *
    Metabolism A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron. Miyamae S, Ueda O, Yoshimura F, Hwang J, Tanaka Y, Nikaido H Antimicrob Agents Chemother 10.1128/AAC.45.12.3341-3346.2001 2001 *
    Pathogenicity Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2. Ednie LM, Jacobs MR, Appelbaum PC J Antimicrob Chemother 10.1093/jac/41.3.387 1998 *
    Pathogenicity Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem. Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CA J Clin Microbiol 10.1128/jcm.28.12.2804-2805.1990 1990 *
    Pathogenicity Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria. Zabransky RJ, Bobey DG, Barry AL, Allen SD, Fuchs PC, Gerlach EH, Thornsberry C, Sheikh W, Jones RN J Clin Microbiol 10.1128/jcm.27.1.190-191.1989 1989 *
    Pathogenicity Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines. Barry AL, Jones RN J Clin Microbiol 10.1128/jcm.26.4.776-777.1988 1988 *
    Pathogenicity Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination. Barry AL, Jones RN J Clin Microbiol 10.1128/jcm.26.1.13-17.1988 1988 *
    Pathogenicity Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques. Sutter VL, Emmerman J, Randall E, Zabransky RJ, Birk RJ Antimicrob Agents Chemother 10.1128/AAC.27.3.424 1985 *

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Field you want to change:


CAPTCHAReload captcha

Change proposal

Successfully sent